T. Rowe Price Investment Management
AVNS

T. Rowe Price Investment Management’s Avanos Medical AVNS Stock Holding History

T. Rowe Price Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,330,776
Closed -$74.7M – 747
2026
Q1 		$74.7M Buy
5,330,776
+860,154
+19% +$11.6M 0.05% 292
2025
Q4 		$50.2M Sell
4,470,622
-242,872
-5% -$2.78M 0.03% 364
2025
Q3 		$54.5M Buy
4,713,494
+716,976
+18% +$8.4M 0.03% 376
2025
Q2 		$48.9M Buy
3,996,518
+238,942
+6% +$3M 0.03% 397
2025
Q1 		$53.8M Buy
3,757,576
+746,264
+25% +$11.7M 0.04% 380
2024
Q4 		$47.9M Buy
3,011,312
+644,267
+27% +$12.8M 0.03% 411
2024
Q3 		$56.9M Buy
2,367,045
+149,252
+7% +$3.41M 0.03% 387
2024
Q2 		$44.2M Buy
2,217,793
+291,026
+15% +$5.67M 0.03% 402
2024
Q1 		$38.4M Buy
1,926,767
+70,899
+4% +$1.37M 0.02% 435
2023
Q4 		$41.6M Buy
1,855,868
+228,785
+14% +$4.72M 0.03% 408
2023
Q3 		$32.9M Buy
1,627,083
+117,901
+8% +$2.67M 0.02% 422
2023
Q2 		$38.6M Buy
1,509,182
+270,471
+22% +$7.12M 0.03% 408
2023
Q1 		$36.8M Buy
+1,238,711
New +$36M 0.03% 404

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

T. Rowe Price Investment Management's AVNS Position: Q2 2026 in Review

T. Rowe Price Investment Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 5,330,776 shares — an estimated $74.7M sold.

T. Rowe Price Investment Management first reported a position in AVNS in Q1 2023 and held it in 13 quarters. The position peaked at $74.7M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • T. Rowe Price Investment Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 5,330,776 Avanos Medical shares in Q2 2026, an estimated $74.7M.
  • T. Rowe Price Investment Management first reported a position in Avanos Medical in Q1 2023 and held it in 13 quarters.
  • T. Rowe Price Investment Management's Avanos Medical position peaked at $74.7M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.